DE69612660D1 - Pseudotypisierte retrovirale vektoren - Google Patents

Pseudotypisierte retrovirale vektoren

Info

Publication number
DE69612660D1
DE69612660D1 DE69612660T DE69612660T DE69612660D1 DE 69612660 D1 DE69612660 D1 DE 69612660D1 DE 69612660 T DE69612660 T DE 69612660T DE 69612660 T DE69612660 T DE 69612660T DE 69612660 D1 DE69612660 D1 DE 69612660D1
Authority
DE
Germany
Prior art keywords
retroviral vector
pseudotypized
retroviral vectors
retroviral
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69612660T
Other languages
English (en)
Other versions
DE69612660T2 (de
Inventor
Brian Salmons
Joerg Baumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum Muenchen Deutsches Forschung De
Original Assignee
AUSTRIAN NORDIC BIOTHERAPEUTIC
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AUSTRIAN NORDIC BIOTHERAPEUTIC, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical AUSTRIAN NORDIC BIOTHERAPEUTIC
Application granted granted Critical
Publication of DE69612660D1 publication Critical patent/DE69612660D1/de
Publication of DE69612660T2 publication Critical patent/DE69612660T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051Methods of production or purification of viral material
    • C12N2740/13052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Optical Radar Systems And Details Thereof (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
DE69612660T 1995-03-29 1996-03-27 Pseudotypisierte retrovirale vektoren Expired - Lifetime DE69612660T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK32795 1995-03-29
PCT/EP1996/001348 WO1996030533A1 (en) 1995-03-29 1996-03-27 Pseudotyped retroviral particles

Publications (2)

Publication Number Publication Date
DE69612660D1 true DE69612660D1 (de) 2001-06-07
DE69612660T2 DE69612660T2 (de) 2002-04-18

Family

ID=8092296

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69612660T Expired - Lifetime DE69612660T2 (de) 1995-03-29 1996-03-27 Pseudotypisierte retrovirale vektoren

Country Status (8)

Country Link
EP (1) EP0817860B1 (de)
JP (1) JPH11502706A (de)
AT (1) ATE200912T1 (de)
AU (1) AU5274696A (de)
DE (1) DE69612660T2 (de)
DK (1) DK0817860T3 (de)
ES (1) ES2157435T3 (de)
WO (1) WO1996030533A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7470096A (en) * 1995-10-05 1997-04-28 Chiron Corporation Retroviral vectors pseudotyped with srv-3 envelope glycoprotein sequences
ATE207963T1 (de) 1997-02-27 2001-11-15 Bundesrepublik Deutschland Let Retrovirale vektoren, verfahren zu ihrer herstellung und ihre verwendung zur genübertragung in cd4-positive zellen
EP0938904A1 (de) * 1998-02-09 1999-09-01 Leuven Research & Development vzw Säugetierzelltransduktion zur Verwendung in Gentherapie
CA2289918A1 (en) * 1997-05-16 1998-11-26 Leuven Research & Development Vzw Mammalian cell transduction for use in gene therapy
FR2779445B1 (fr) * 1998-06-08 2000-08-11 Univ Nantes Kit d'encapsidation
GB0400443D0 (en) 2004-01-09 2004-02-11 Oxford Biomedica Ltd Cascade
EP1427836A2 (de) * 2001-09-21 2004-06-16 Oxford Biomedica (UK) Limited Pseudotyped retrovirales vektorsystem

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69420033T2 (de) * 1993-04-06 1999-12-23 Us Gov Health & Human Serv Gibbon leukemia virus retrovirale vektoren

Also Published As

Publication number Publication date
AU5274696A (en) 1996-10-16
DK0817860T3 (da) 2001-10-01
ATE200912T1 (de) 2001-05-15
DE69612660T2 (de) 2002-04-18
EP0817860A1 (de) 1998-01-14
JPH11502706A (ja) 1999-03-09
ES2157435T3 (es) 2001-08-16
EP0817860B1 (de) 2001-05-02
WO1996030533A1 (en) 1996-10-03

Similar Documents

Publication Publication Date Title
GB2331522A (en) Lentiviral vectors
GB2325003A (en) Rectroviral vectors
CA2324028A1 (en) Retroviral packaging cell line
ATE381624T1 (de) Retrovirale vektoren mit verminderter rekombinationsrate
ATE291632T1 (de) Auf lentivirus basierende gentransfer-vektoren
MX9205244A (es) Micelas modificadas de caseina.
DE69612660T2 (de) Pseudotypisierte retrovirale vektoren
EP1006196A3 (de) Retrovirale, mit LCMV-Glykoprotein pseudotypisierte Hybrid-Vektoren
NO975813L (no) Innkapslede celler som produserer virale partikler
DE3789400D1 (de) Für ein Glykoprotein des AIDS-Virus kodierende Virus-Vektoren, Vakzin und Antikörper.
DE69739251D1 (de) Nicht-m nicht-o hiv-1-stamm, fragmente und verwendungen
WO2002042482A3 (en) Functional lentiviral vector from an mlv-based backbone
CA2464268A1 (en) Regulated nucleic acid expression system
ES2184059T3 (es) Vector retrovirico y su utilizacion en terapia genica.
NO20002013D0 (no) Suspensjonsforpakningscellelinjer for retrovirusvektorer
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
WO1995025806A3 (en) Packaging-deficient lentiviruses
CA2331440A1 (en) Amphotropic retrovirus packaging cell line, process for its production and use thereof
WO2002034929A3 (en) Expression vectors and uses thereof
EP1129100A4 (de) Auswahlverfahren zur erzeugung effizienter pack-zellen für lentivirale vektoren
WO1999025862A3 (en) Chimeric viral packaging signal without gag gene sequences

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GSF - FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT

8327 Change in the person/name/address of the patent owner

Owner name: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNG, DE